June 18, 2024 Columns by Ahna Crum Embracing the unknown in Russia taught me a crucial lesson Note: This column describes the authorās own experiences with an autologous hematopoietic stem cell transplant (aHSCT). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. In June 2016, I traveled to Moscow with two friends. The first evening we were…
April 11, 2024 News by Steve Bryson, PhD Stem cell transplant alters immune cells in MS mouse model: Study A stem cell transplant effectively reduced the abnormal immune response that drives multiple sclerosis (MS) progression by altering a specific group of immune cells called myeloid cells, a mouse study showed. Treatment with a compound that suppressed a receptor called CSF1R improved the transplantation efficiency of myeloid cells…
March 22, 2022 News by Hawken Miller Stem Cell Transplant Gaining Ground as MS Therapy Option Nothing was working for Jennifer Stansbury Koenig, who was diagnosed with relapsing-remitting multiple sclerosis (RRMS) in 2010 the day before she learned she was pregnant. The first disease-modifying therapy (DMT) Koenig started in 2013, Tecfidera (dimethyl fumarate), an oral capsule developed and marketed by Biogen, made her…
February 11, 2022 News by Margarida Maia, PhD Blood Stem Cell Transplant May Help Immune System Longer Treatment with an autologous hematopoietic stem cell transplant (aHSCT) seems to reboot the immune system in multiple sclerosis (MS) patients for at least three years, a small study found. The study, āSustained immunotolerance in multiple sclerosis after stem cell transplant,ā was published in Annals of Clinical and…
October 18, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: AHSCT for SPMS, Rituximab, Sativex, Smoking This week’s column focuses on stories from Multiple Sclerosis News Today reporters who have been following the annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis, or ECTRIMS. #ECTRIMS2021 ā Stem Cell Transplant May Better Treat SPMS Than DMTs This presentation involves autologous…
October 30, 2020 Columns by Ed Tobias aHSCT Gets a Boost in US With NMSS Recommendations Is the United States a step closer to approving a form of stem cell transplantation as a treatment for multiple sclerosis? I believe it may be. That’s because the National Multiple Sclerosis Society (NMSS) has slightly changed its view of autologous hematopoietic stem cell transplantation, or aHSCT. aHSCT involves…
June 14, 2016 News by Patricia Silva, PhD Aggressive Stem Cell Transplant Approach Halts MS for Years, But Risks are High Autologous haematopoietic stem cell transplantation (aHSCT) has been used to stop autoimmune processes in multiple sclerosis (MS), althoughĀ the treatment is not effectiveĀ for every person. Now, an improved version of the technique is showing astonishingly good results, with patients free ofĀ both the need for treatment and the risk of relapses for…
August 4, 2014 News by Patricia Silva, PhD UPDATE: Australian Authorities Warn About Unapproved MS Stem Cell Treatments After Death in Russia Australian authorities are alerting Multiple Sclerosis patients to the risk of unproven stem cell treatments that are being performed both in the country and overseas, after the recent death of a woman in Russia undergoing a controversial treatment for the disease. The continued marketing campaigns to…